Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: 360iResearch | PRODUCT CODE: 1715433

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1715433

Marine Derived Drugs Market by Source, Drug Type, Form, Applications, End-User - Global Forecast 2025-2030

PUBLISHED:
PAGES: 184 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (2-5 User License)
USD 4249
PDF, Excel & 1 Year Online Access (Site License)
USD 5759
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

Description

Table of Contents

List of Tables

The Marine Derived Drugs Market was valued at USD 4.39 billion in 2024 and is projected to grow to USD 4.77 billion in 2025, with a CAGR of 9.29%, reaching USD 7.48 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 4.39 billion
Estimated Year [2025] USD 4.77 billion
Forecast Year [2030] USD 7.48 billion
CAGR (%) 9.29%

Marine environments have long been a reservoir of bioactive compounds, offering unique molecules that have the potential to revolutionize modern medicine. In recent decades, scientific advances coupled with technological innovations have enabled researchers to tap into the vast potential of marine-derived substances. These compounds, harvested from sources ranging from algae to sponges, have started to drive a renaissance in drug discovery and therapeutic interventions. The research and development in this field have opened up new avenues for addressing complex diseases and overcoming resistance to traditional pharmaceuticals.

The exploration of marine ecosystems not only brings forth innovative drug candidates but also enriches our understanding of biochemical pathways that were previously unexplored in terrestrial organisms. As industries diversify their research portfolios, the emphasis on natural marine compounds has grown significantly. The integration of advanced genomics, metabolomics, and bioassay techniques has further accelerated this progress. With an increasing number of clinical trials and regulatory approvals, the marine derived drugs sector stands at the confluence of innovation, scientific rigor, and market demand, indicating a promising future for novel therapeutics.

This comprehensive analysis provides a detailed overview of the evolving landscape, drawing insights from extensive market research and expert opinions. It aims to inform decision-makers and industry veterans by offering a deep dive into the innovative strategies, segmentation insights, and regional dynamics influencing the marine derived drugs market.

Transformative Shifts in the Marine Derived Drugs Landscape

Recent years have witnessed transformative shifts within the marine derived drugs landscape, driven by the convergence of cutting-edge research methodologies and a renewed interest in natural product discovery. The evolution of extraction and purification processes has allowed for a more sustainable harvesting of bioactive compounds sourced directly from the marine environment. With scientific advancements, the industry has moved from rudimentary screening techniques to sophisticated high-throughput analyses, ensuring that promising compounds are rapidly identified and characterized.

Additionally, breakthroughs in biotechnology have empowered researchers to engineer microbes and algae, enabling them to produce targeted bioactives at scale. This shift has not only streamlined production but has also mitigated supply chain challenges that have traditionally plagued the marine drugs sector. Regulatory frameworks are also adapting to balance the need for innovation with safety, thereby fast-tracking the approval of new drugs without compromising on clinical efficacy.

The advent of interdisciplinary collaborations has further bolstered progress in this field. Cross-sector partnerships between academic institutions, biotech firms, and pharmaceutical giants have accelerated the pace at which novel marine compounds are integrated into therapeutic regimes. These developments mark a turning point, as stakeholders now explore previously uncharted territories, harnessing the unique chemical properties of marine-sourced agents. The landscape is thus evolving into a dynamic and competitive arena where innovation and sustainability go hand in hand.

Key Segmentation Insights of the Marine Derived Drugs Market

An in-depth analysis of market segmentation reveals an intricate and multifaceted structure that classifies the marine derived drugs market across several critical dimensions. The segmentation based on source investigates components derived from various biological origins. The market is analyzed from sources such as macroalgae, marine bacteria, marine fungi, marine sponges, and microalgae. Within these broad categories, further investigation highlights that macroalgae is subdivided into brown seaweed, green seaweed, and red seaweed, while marine bacteria are further segmented into actinobacteria and proteobacteria. Marine sponges are examined with a focus on specific species such as Halichondria okadai and Theonella zwinhoei, and microalgae are scrutinized across species including Chlorella, Dunaliella, and Spirulina.

Segmentation based on drug type addresses the therapeutic categories that these marine compounds are poised to influence. This covers a wide array of drug types, including anti-inflammatory agents, antibiotics, anticancer agents, antimicrobial, antiviral agents, and cardiovascular drugs. A deeper look into the drug types reveals that antibiotics are differentiated into broad-spectrum antibiotics and narrow-spectrum antibiotics. Similarly, anticancer agents extend into apoptotic agents and cytotoxic drugs, while antiviral agents are delineated into influenza treatment and retroviral treatment, and cardiovascular drugs include both anticoagulants and blood pressure regulators.

Beyond the source and type, the segmentation is also categorized based on the physical form of the compounds, analyzing whether these drugs exist in liquid, semi solid, or solid formulations. Furthermore, when viewed through the lens of application, the market segments into cosmeceuticals, nutraceuticals, and pharmaceuticals. Within these application categories, cosmeceuticals are refined into hair care and skin care, nutraceuticals further into dietary supplements and functional foods, and pharmaceuticals primarily into cardiovascular and oncology realms. Lastly, market segmentation by end-user distinguishes between hospitals and clinics and research as well as academic institutions. These insights not only clarify the distinct segments but also help stakeholders understand areas of high potential and focus, thus guiding strategic investments and product development trajectories.

Based on Source, market is studied across Macroalgae, Marine Bacteria, Marine Fungi, Marine Sponges, and Microalgae. The Macroalgae is further studied across Brown Seaweed, Green Seaweed, and Red Seaweed. The Marine Bacteria is further studied across Actinobacteria and Proteobacteria. The Marine Sponges is further studied across Halichondria Okadai and Theonella Zwinhoei. The Microalgae is further studied across Chlorella, Dunaliella, and Spirulina.

Based on Drug Type, market is studied across Anti-Inflammatory Agents, Antibiotics, Anticancer Agents, Antimicrobial, Antiviral Agents, and Cardiovascular Drugs. The Antibiotics is further studied across Broad-Spectrum Antibiotics and Narrow-Spectrum Antibiotics. The Anticancer Agents is further studied across Apoptotic Agents and Cytotoxic Drugs. The Antiviral Agents is further studied across Influenza Treatment and Retroviral Treatment. The Cardiovascular Drugs is further studied across Anticoagulants and Blood Pressure Regulators.

Based on Form, market is studied across Liquid, Semi Solid, and Solid.

Based on Applications, market is studied across Cosmeceuticals, Nutraceuticals, and Pharmaceuticals. The Cosmeceuticals is further studied across Hair Care and Skin Care. The Nutraceuticals is further studied across Dietary Supplements and Functional Foods. The Pharmaceuticals is further studied across Cardiovascular and Oncology.

Based on End-User, market is studied across Hospitals & Clinics and Research & Academic Institutions.

Geographic Landscape and Key Regional Insights

A robust analysis of the marine derived drugs market unravels significant regional variations that offer both opportunities and challenges. In the Americas, the emphasis on advanced biotechnological research integrated with established pharmaceutical frameworks has created a fertile ground for innovation and commercialization. Research centers and vigorously supported academic institutions in this region have driven the discovery and development of novel marine-based therapeutics.

Across Europe, the Middle East, and Africa, stringent regulatory standards coupled with a strong commitment to sustainable practices have fostered an environment that encourages high-quality research while preserving natural marine ecosystems. This region is characterized by a balanced approach, where economic stability meets rigorous compliance, ensuring that new products are both effective and environmentally conscious.

The Asia-Pacific region, on the other hand, is emerging as a critical hub for marine derived drugs due to its rich biodiversity and rapid advancements in pharmaceutical research. Here, investments in technology and growing consumer demand have propelled the market forward. While market dynamics vary across these regions, the overall landscape reflects a trend towards increased collaboration in research, the integration of innovative technologies, and a commitment to developing sustainable therapeutics for complex diseases.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The competitive landscape in the marine derived drugs market is notably characterized by an assortment of pioneering companies that are shaping the future of pharmaceutical innovation. Industry frontrunners such as Archimica S.p.A and Asahi Kasei Finechem Co., Ltd. are known for their robust research frameworks and commitment to sustainable practices. Companies like BASF Pharma (Callanish) Limited and Biesterfeld SE have made significant strides by investing in state-of-the-art processing technologies and establishing strong research pipelines.

Other key players including BioMarin Pharmaceutical Inc. and Bristol-Myers Squibb Company are well-regarded for their contributions to translating marine bioactives into clinically relevant therapeutics. They continue to collaborate with academic institutions and research organizations to harness novel molecules from marine ecosystems. Firms such as DSM-Firmenich AG, Eli Lilly and Company, and F. Hoffmann-La Roche Ltd are pushing the envelope in terms of technological innovation and regulatory compliance, thereby setting benchmarks in quality assurance and efficacy. Emerging players like LGM Pharma and Mac-Chem Products (India) Pvt. Ltd are rapidly gaining traction by pioneering innovative approaches in extraction and formulation. Additionally, companies like MARINE LIFESCIENCES, Marinomed Biotech AG, Pfizer Inc., Pharmamar S.A., Takeda Pharmaceutical Company Limited, and Zhejiang Hisun Pharmaceutical Co. Ltd have carved out niche positions by continuously adapting to market trends and forming strategic collaborations. The collective efforts of these organizations have paved the way for transformative therapies that leverage the unique molecular architecture of marine organisms.

The report delves into recent significant developments in the Marine Derived Drugs Market, highlighting leading vendors and their innovative profiles. These include Archimica S.p.A, Asahi Kasei Finechem Co., Ltd., BASF Pharma (Callanish) Limited, Biesterfeld SE, BioMarin Pharmaceutical Inc., Bristol-Myers Squibb Company, DSM-Firmenich AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, LGM Pharma, Mac-Chem Products (India) Pvt.Ltd, MARINE LIFESCIENCES, Marinomed Biotech AG, Pfizer Inc., Pharmamar S.A., Takeda Pharmaceutical Company Limited., and Zhejiang Hisun Pharmaceutical Co. Ltdv. Actionable Recommendations for Industry Leaders

Industry leaders should consider adopting strategies that emphasize the integration of advanced technologies and collaborative research, ensuring that operations align with evolving market demands. As novel compounds from marine sources continue to emerge, it becomes essential to invest in research and development pipelines that fully exploit the chemical diversity offered by marine ecosystems. Leaders are encouraged to forge strategic partnerships with academic institutions and research centers to validate the efficacy of these natural products, thereby accelerating time-to-market.

Embracing a multi-disciplinary approach, stakeholders should consider incorporating next-generation methodologies such as AI-driven data analytics for more efficient screening and characterization of marine bioactives. Emphasis on sustainable harvesting and environmentally responsible practices is also pivotal to ensure long-term viability and regulatory compliance. Streamlining supply chains through innovative bioprocessing techniques can further bolster the competitive edge of organizations. In a rapidly evolving landscape, maintaining agility in product development and fostering a culture of continuous improvement can drive the successful translation of promising marine compounds into market-ready solutions.

Lastly, clear communication with regulatory bodies and proactive involvement in shaping policy standards will enhance market confidence. This holistic approach, combining technological innovation with sustainable practices, is key to unlocking considerable value and achieving long-term success in the dynamic marine derived drugs market.

Comprehensive Conclusion on Future Directions

In conclusion, the marine derived drugs market presents a compelling narrative defined by innovation, sustainable sourcing, and breakthrough therapeutic offerings. Significant transitions in research methodologies and industry dynamics have catalyzed the integration of marine bioactives into mainstream pharmaceutical applications. The segmentation insights across source, drug type, form, application, and end-user categories have provided a nuanced understanding of a market that is both diverse and rapidly evolving. Regional differences highlight areas of opportunity for targeted investments and research collaborations, while the competitive landscape demonstrates a convergence of established industry giants and agile innovators.

As we look forward, the continued interplay between technological advancements and environmental stewardship will be pivotal in driving the industry into new realms of scientific discovery. Stakeholders must remain vigilant and adaptable, leveraging strategic initiatives that align with the future trajectory of marine derived therapeutics.

Show more
Product Code: MRR-437A48C79EDF

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases driving demand for new and effective treatment options
      • 5.1.1.2. Rising interest and demand for personalized medicine fueling innovations in marine pharmacology
      • 5.1.1.3. Growing acceptance and usage of natural and organic elements in therapeutic drugs and treatments
    • 5.1.2. Restraints
      • 5.1.2.1. Lengthy approval and expensive drug development process
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in marine biotechnology expanding possibilities for new drug discovery
      • 5.1.3.2. Leveraging marine biochemicals for the development of rare disease treatment protocols globally
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity and limited understanding of marine ecosystems and organisms
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Source: Growing adoption of macroalgae due to their fucoidans and phlorotannins that offer antiviral and anti-inflammatory properties
    • 5.2.2. End-User: Rising application of marine derived drugs in the cosmeceuticals sector to maintain healthy hair and skin
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Marine Derived Drugs Market, by Source

  • 6.1. Introduction
  • 6.2. Macroalgae
    • 6.2.1. Brown Seaweed
    • 6.2.2. Green Seaweed
    • 6.2.3. Red Seaweed
  • 6.3. Marine Bacteria
    • 6.3.1. Actinobacteria
    • 6.3.2. Proteobacteria
  • 6.4. Marine Fungi
  • 6.5. Marine Sponges
    • 6.5.1. Halichondria Okadai
    • 6.5.2. Theonella Zwinhoei
  • 6.6. Microalgae
    • 6.6.1. Chlorella
    • 6.6.2. Dunaliella
    • 6.6.3. Spirulina

7. Marine Derived Drugs Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Anti-Inflammatory Agents
  • 7.3. Antibiotics
    • 7.3.1. Broad-Spectrum Antibiotics
    • 7.3.2. Narrow-Spectrum Antibiotics
  • 7.4. Anticancer Agents
    • 7.4.1. Apoptotic Agents
    • 7.4.2. Cytotoxic Drugs
  • 7.5. Antimicrobial
  • 7.6. Antiviral Agents
    • 7.6.1. Influenza Treatment
    • 7.6.2. Retroviral Treatment
  • 7.7. Cardiovascular Drugs
    • 7.7.1. Anticoagulants
    • 7.7.2. Blood Pressure Regulators

8. Marine Derived Drugs Market, by Form

  • 8.1. Introduction
  • 8.2. Liquid
  • 8.3. Semi Solid
  • 8.4. Solid

9. Marine Derived Drugs Market, by Applications

  • 9.1. Introduction
  • 9.2. Cosmeceuticals
    • 9.2.1. Hair Care
    • 9.2.2. Skin Care
  • 9.3. Nutraceuticals
    • 9.3.1. Dietary Supplements
    • 9.3.2. Functional Foods
  • 9.4. Pharmaceuticals
    • 9.4.1. Cardiovascular
    • 9.4.2. Oncology

10. Marine Derived Drugs Market, by End-User

  • 10.1. Introduction
  • 10.2. Hospitals & Clinics
  • 10.3. Research & Academic Institutions

11. Americas Marine Derived Drugs Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Marine Derived Drugs Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Marine Derived Drugs Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. UC San Diego innovates Algae-based microbot technology for enhanced lung tumor drug delivery
    • 14.3.2. GITAM secures INR 13.69 crore for innovative marine drug discovery center to combat cancer and antibiotic resistance
    • 14.3.3. Unimed strengthens global maritime medical presence through strategic merger with Marine Pharma in Singapore
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Archimica S.p.A
  • 2. Asahi Kasei Finechem Co., Ltd.
  • 3. BASF Pharma (Callanish) Limited
  • 4. Biesterfeld SE
  • 5. BioMarin Pharmaceutical Inc.
  • 6. Bristol-Myers Squibb Company
  • 7. DSM-Firmenich AG
  • 8. Eli Lilly and Company
  • 9. F. Hoffmann-La Roche Ltd
  • 10. LGM Pharma
  • 11. Mac-Chem Products (India) Pvt.Ltd
  • 12. MARINE LIFESCIENCES
  • 13. Marinomed Biotech AG
  • 14. Pfizer Inc.
  • 15. Pharmamar S.A.
  • 16. Takeda Pharmaceutical Company Limited.
  • 17. Zhejiang Hisun Pharmaceutical Co. Ltdv
Show more
Product Code: MRR-437A48C79EDF

LIST OF FIGURES

  • FIGURE 1. MARINE DERIVED DRUGS MARKET MULTI-CURRENCY
  • FIGURE 2. MARINE DERIVED DRUGS MARKET MULTI-LANGUAGE
  • FIGURE 3. MARINE DERIVED DRUGS MARKET RESEARCH PROCESS
  • FIGURE 4. MARINE DERIVED DRUGS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. MARINE DERIVED DRUGS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. MARINE DERIVED DRUGS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MARINE DERIVED DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MARINE DERIVED DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY BROWN SEAWEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY GREEN SEAWEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY RED SEAWEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ACTINOBACTERIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY PROTEOBACTERIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE FUNGI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY HALICHONDRIA OKADAI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY THEONELLA ZWINHOEI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CHLORELLA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DUNALIELLA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SPIRULINA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY APOPTOTIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CYTOTOXIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY INFLUENZA TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY RETROVIRAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICOAGULANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY BLOOD PRESSURE REGULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SEMI SOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 90. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 91. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 92. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 93. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 97. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 98. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 101. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 102. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 103. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 104. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 106. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 107. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 108. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 109. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 110. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 112. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 113. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 114. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 116. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 117. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 118. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 119. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 120. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 122. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 123. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 124. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 125. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 126. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 127. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 128. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 129. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 130. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 132. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 133. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 134. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 135. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 136. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 138. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 139. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 140. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 143. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 144. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 145. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 146. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 155. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 156. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 157. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 158. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 159. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 160. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 161. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 162. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 182. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 184. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 185. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 186. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 188. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 189. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 190. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 192. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 193. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 194. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 195. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 196. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 198. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 199. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 200. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 201. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 202. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 204. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 205. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 206. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 207. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 208. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 209. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 210. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 211. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 212. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 214. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 215. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 216. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 217. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 218. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 220. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 221. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 222. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 223. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 224. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 225. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 226. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 227. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 228. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 230. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 231. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 232. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 233. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 234. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 236. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 237. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 238. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 239. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 240. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 242. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 243. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 244. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 246. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 247. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 248. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 249. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 250. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 252. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 253. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 254. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 255. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 256. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 257. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 258. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 259. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 260. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 262. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 263. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 264. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 265. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 266. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 268. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 269. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 270. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 271. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 272. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 273. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 274. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 275. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 276. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 278. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 279. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 280. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 281. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 282. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 284. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 285. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 286. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 287. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 288. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 289. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 290. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 291. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 292. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 293. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 294. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 295. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 296. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 297. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 298. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 300. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 301. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 302. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 303. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 304. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 305. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 306. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 307. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 308. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 309. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 310. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 311. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 312. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 313. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 314. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 325. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 326. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2030 (USD MILLION)
  • TABLE 327. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2030 (USD MILLION)
  • TABLE 328. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2030 (USD MILLION)
  • TABLE 329. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2030 (USD MILLION)
  • TABLE 330. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 331. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
  • TABLE 332. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2030 (USD MILLION)
  • TABLE 333. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2030 (USD MILLION)
  • TABLE 334. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2030 (USD MILLION)
  • TABLE 335. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 336. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 337. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 338. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 339. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 340. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 341. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 342. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!